Anticoagulation: where we are and where we need to go

被引:0
|
作者
Geoffrey D. Barnes
James B. Froehlich
机构
[1] University of Michigan Cardiovascular Center,
来源
关键词
Anticoagulation; Warfarin; Anticoagulation clinic;
D O I
暂无
中图分类号
学科分类号
摘要
Although a commonly prescribed medication, warfarin has unique pharmacologic properties that make dosing challenging for many primary care physicians. When a patient’s international normalized ratio (INR) is out of the therapeutic range, they are at increased risk for thrombotic or hemorrhagic complications. We have reviewed the current literature for quality improvement techniques to minimize adverse outcomes and improve anticoagulation care. The use of anticoagulation clinics, computer-guided dosing and patient self-monitoring have been demonstrated to reduce adverse events or improve patient and provider satisfaction. Additional techniques, including genetic-based dosing, concurrent vitamin K administration and development of risk-assessment tools, have been discussed, but not fully developed or assessed in the literature. We identify tools that can be implemented today as well as those currently under development for the improvement in anticoagulation care.
引用
收藏
相关论文
共 50 条
  • [1] Anticoagulation: where we are and where we need to go
    Barnes, Geoffrey D.
    Froehlich, James B.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 28 (02) : 220 - 223
  • [2] The Holocaust -: Where we are, where we need to go
    Jäckel, E
    [J]. HOLOCAUST AND HISTORY: THE KNOWN, THE UNKNOWN, THE DISPUTED, AND THE REEXAMINED, 1998, : 23 - 29
  • [3] Synucleinopathies: Where we are and where we need to go
    Bras, Ines Caldeira
    Dominguez-Meijide, Antonio
    Gerhardt, Ellen
    Koss, David
    Lazaro, Diana F.
    Santos, Patricia, I
    Vasili, Eftychia
    Xylaki, Mary
    Outeiro, Tiago Fleming
    [J]. JOURNAL OF NEUROCHEMISTRY, 2020, 153 (04) : 433 - 454
  • [4] Diversity in Neuromodulators: Where We Are and Where We Need to Go
    Sabourin, Shelby
    Omoruan, Moje
    Khazen, Olga
    DiMarzio, Marisa
    Sofatzis, Tia
    Staples, Sarah
    Feustel, Paul J.
    Petersen, Erika
    Casini, Gianna
    Spinoza, Zulma T.
    Pilitsis, Julie G.
    [J]. NEUROMODULATION, 2020, 23 (02): : 145 - 149
  • [5] Pharmacoeconomics in 2000: Where we are, where we need to go
    Lyles, A
    [J]. FORMULARY, 2000, 35 (05) : 422 - +
  • [6] Measuring acculturation: Where we are and where we need to go
    Cabassa, LJ
    [J]. HISPANIC JOURNAL OF BEHAVIORAL SCIENCES, 2003, 25 (02) : 127 - 146
  • [7] The Holocaust - Where we are, where we need to go - A comment
    Marrus, MR
    [J]. HOLOCAUST AND HISTORY: THE KNOWN, THE UNKNOWN, THE DISPUTED, AND THE REEXAMINED, 1998, : 30 - 34
  • [8] Molecular oncodiagnostics: Where we are and where we need to go
    Liu, ET
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (11) : 2052 - 2055
  • [9] Surgeons and Professionalism: Where We Are and Where We Need to Go
    Olortegui, Kinga Skowron
    Angelos, Peter
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (03) : 544 - 548
  • [10] Modeling the fontan circulation: Where we are and where we need to go
    DeGroff, C. G.
    [J]. PEDIATRIC CARDIOLOGY, 2008, 29 (01) : 3 - 12